Cardio Diagnostics Holdings Income Statement (2021-2025) | CDIO

Income Statement Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 950.000.00M0.01M0.01M0.02M0.01M0.01M0.00M940.000.01M0.00M
Cost of Revenue 0.02M0.03M0.02M0.03M0.05M0.03M0.03M0.04M0.03M0.06M0.05M0.04M0.04M
Gross Profit -0.02M-0.03M-0.02M-0.03M-0.05M-0.03M-0.02M-0.04M-0.02M-0.05M-0.05M-0.03M-0.04M
Operating items
Research & Development 0.00M0.01M0.00M0.03M0.09M0.01M0.04M0.01M0.01M0.01M0.01M0.01M0.00M
Selling, General & Administrative 0.21M0.75M1.13M2.32M1.56M2.51M1.38M1.49M4.12M1.29M1.42M1.29M1.54M1.69M1.71M
Restructuring Costs 0.06M0.06M
Other Operating Expenses 397.00721.000.02M-0.03M-0.02M0.02M0.03M0.05M0.04M0.04M0.05M0.04M-0.01M-0.01M0.23M0.09M
Operating Expenses 397.00721.000.02M0.23M0.79M1.15M2.38M1.70M2.55M1.45M1.55M4.17M1.29M1.42M1.52M1.63M1.69M1.71M
Operating Income -397.00-721.00-0.15M-0.25M-0.79M-1.15M-2.38M-1.70M-2.55M-1.44M-1.54M-4.16M-1.28M-1.41M-1.52M-1.63M-1.68M-1.71M
EBIT -397.00-721.00-0.15M-0.25M-0.79M-1.15M-2.38M-1.70M-2.55M-1.44M-1.54M-4.16M-1.28M-1.41M-1.52M-1.63M-1.68M-1.71M
Non-operating items
Non Operating Investment Income 484.000.01M0.37M
Other Non Operating Income -0.06M-0.06M0.67M-1.47M-0.49M0.15M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M
Non Operating Income -0.06M-0.06M0.67M-1.47M-0.49M0.15M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M
Net income details
EBT -397.00-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M
Profit After Tax -397.00-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M
Income from Continuing Operations -397.00-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M
Consolidated Net Income -397.00-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M
Income towards Parent Company -397.00-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M
Net Income towards Common Stockholders -397.00-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M
Additional items
EPS (Basic) -0.12-0.07-0.16-0.17-0.77-0.11-0.39-0.16-0.11-5.93-1.71-1.73-0.06-0.97-0.97-0.98
EPS (Weighted Average and Diluted) -0.12-0.07-0.16-0.17-0.77-0.11-0.39-0.16-0.11-5.93-1.71-1.73-0.06-0.97-0.97-0.98
Shares Outstanding (Weighted Average) 1.16M4.22M5.43M6.61M3.09M9.55M10.24M11.90M12.69M0.70M0.75M0.81M26.89M1.69M1.74M1.76M
Shares Outstanding (Diluted Average) 1.16M4.22M5.43M6.61M3.09M9.55M10.24M11.90M12.69M0.70M0.75M0.81M26.89M1.69M1.74M1.76M
EBITDA -397.00-721.00-0.15M-0.25M-0.79M-1.15M-2.38M-1.70M-2.55M-1.44M-1.54M-4.16M-1.28M-1.41M-1.52M-1.63M-1.68M-1.71M
Interest Expenses 5.02M1.05M0.57M0.10M0.01M0.01M0.00M0.00M0.00M0.00M0.00M